X-ray phase tomography is an imaging technique that uses
penetrating1 X-rays to create volumetric views through "slices" or sections of soft biological tissues, such as tumors, and it offers strongly enhanced contrast compared to conventional CT scans. Yet scientists still do not know which X-ray phase tomography methods are best suited to yield
optimized2 results for a wide variety of conditions. To answer this question, a large group of researchers in Europe set out to compare three different X-ray phase tomography methods at the European Synchrotron Radiation Facility's (ESRF) beamline ID19 in France -- X-ray grating interferometry, propagation-based phase tomography with single-distance phase
reconstruction3, and holotomography.
Led by Irene Zanette, a scientist
affiliated4 with both ESRF and the Technische Universität München (TUM) in Germany, the researchers put these three techniques to the test by examining cancerous tissue from a mouse model and an entire rat's heart, which they report this week in the Journal of
Applied5 Physics, from AIP Publishing.
Along with colleagues Bert Müller, group leader of the Biomaterials Science Center in Switzerland, and Timm Weitkamp, a scientist at the Synchrotron SOLEIL in France, the team explored which method performs best in terms of
spatial6 resolution and visualization/quantification of relevant features in the samples. They also investigated other related factors such as the
simplicity7 of the setup, and the data acquisition and analysis involved in each method.
To do this, the researchers chose to exploit synchrotron radiation, which produces significantly higher-quality X-rays than conventional X-ray
generators8 such as those found in hospitals.
What exactly is synchrotron radiation? "Think of synchrotron radiation as being
analogous9 to the sort of
monochromatic10, collimated and intense light produced by lasers, while conventional X-ray generators in hospitals are more analogous to light bulbs we use within our homes," explained Zanette, currently a postdoctoral scientist in biomedical physics at TUM in Germany.